This is used for Pipeline or other output lists that are grouped by project area. Name will NOT output.
Administrator Kenny is TAG's Administrator, and he joined the organization in July 2026. He supports TAG's operations and systems so that the organization can focus on its mission in research, advocacy, and equity. Kenny has worked in nonprofits since 2013,…
This year marks our 6th Annual Pride Health Fair — a necessary act of political resistance in response to attacks on healthcare, LGBTQIA+ communities, and human dignity. As healthcare becomes unaffordable, this event remains a opportunity to access care while building community power.
The White House Office Of Management and Budget (OMB) under the direction of Russell Vought is seeking a regulatory blessing to use Federal grant funding as a tool for political extortion, violation of due process, and further undermining of scientific integrity. Targets include scientists, institutions, organizations, States, cities, and other recipients who might fail an extreme right wing, Christian nationalist, anti-science political litmus test.
Ending HIV requires sustained research. TAG’s June 2026 cure trials update tracks clinical studies worldwide, helping advocates, researchers, and communities follow progress toward a cure.
Treatment Action Group (TAG) is profoundly troubled by recent reporting that the NIH’s longstanding Notice of Funding Opportunity (NOFO) process is being interrupted and delayed by political interference.
Grant Officer Jake joined TAG in May 2026 as Grant Officer, creating and managing grant initiatives and systems to support TAG's 34 years of leadership in research and policy advocacy to end the epidemics of HIV, tuberculosis (TB), and hepatitis…
TAG's most important fundraising event of the year, our Research in Action Awards (RIAA), will take place on Thursday, October 15, 2026, at the Angel Orensanz Foundation, 172 Norfolk Street, New York City, from 6-9 p.m. Save the date or get your tickets now!
TAG's leadership and staff broke down the latest in HIV, TB, and hepatitis C research and advocacy. See where the work stands and where it's headed.
CDC pauses rabies, mpox, and other infectious disease testing amid budget cuts and staffing losses, raising urgent public health concerns.
TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID's continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), the HIV Prevention Trials Network (HPTN), and the HIV Vaccine Trials Network (HVTN) or the updated IBPTN.
Your donation will bring progress, healing, and hope — turning the promise of innovative research into a brighter, healthier future for all.
